Yiyu Zou - Concepedia

Author

Yiyu Zou

Albert Einstein College of Medicine ORCID

Also Known As

Y Y Zou, Y Zou, YIYU ZOU, Yiyu Zou, yiyu Zou

171

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Albert Einstein College of Medicine The University of Texas MD Anderson Cancer Center Montefiore Medical Center Yeshiva University New York University

About

Yiyu Zou is an author at Albert Einstein College of Medicine specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	2.6K
2	Biochemistry	3	3	99
3	Health Sciences	2	2	67
4	Engineering	1	1	25
5	Natural Sciences	1	1	60

Yiyu Zou

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation Binhua P. Zhou, Yong Liao, Weiya Xia, Nature Cell Biology Cell RegulationMedicineHer-2/neu InducesTumor SuppressorCancer Biology	2001	937
IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a Mickey C.‐T. Hu, Dung‐Fang Lee, Weiya Xia, Cell Forkhead Foxo3aSignal TransductionSignaling PathwayCell RegulationMedicine	2004	861
A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth Bin‐Zhi Qian, Yan Deng, Jae Hong Im, PLoS ONE	2009	652
Reactive Oxygen Species Generation and Mitochondrial Dysfunction in the Apoptotic Response to Bortezomib, a Novel Proteasome Inhibitor, in Human H460 Non-small Cell Lung Cancer Cells Yi‐He Ling, Leonard Liebes, Yiyu Zou, Journal of Biological Chemistry	2003	459
Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts Tushar D. Bhagat, Dagny Von Ahrens, Meelad M. Dawlaty, eLife	2019	162
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis Yiyu Zou, Wen-Bin Tsai, Chien-Jui Cheng, Breast Cancer Research	2008	155
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib Yiyu Zou, Yi‐He Ling, Juan Sironi, Journal of Thoracic Oncology Cell AutophagyMedicineAutophagyImmunologyCell Death	2013	131
Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma Niraj Shenoy, Tushar D. Bhagat, John C. Cheville, Journal of Clinical Investigation Chemoprevention StrategyPrimary Ccrcc SamplesRenal InflammationCell DeathEpigenetics	2019	110
<i>RICTOR</i> Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors Haiying Cheng, Yiyu Zou, Jeffrey S. Ross, Cancer Discovery	2015	100
Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer Ritesh K. Aggarwal, Rebecca A. Luchtel, Venkata R. Machha, Proceedings of the National Academy of Sciences	2021	86

Page 1